Lau Associates continued to hold its stake in shares of Cerner Co. (NASDAQ:CERN) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,650 shares of the company’s stock at the end of the fourth quarter. Lau Associates’ holdings in Cerner were worth $280,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. LGT Capital Partners purchased a new position in Cerner during the fourth quarter valued at $963,000. MUFG Americas increased its position in Cerner by 122.6% in the third quarter. MUFG Americas now owns 17,638 shares of the company’s stock valued at $1,058,000 after buying an additional 9,716 shares in the last quarter. Capital Investment Services of America increased its position in Cerner by 1.2% in the fourth quarter. Capital Investment Services of America now owns 185,182 shares of the company’s stock valued at $11,142,000 after buying an additional 2,250 shares in the last quarter. Eagle Asset Management increased its position in Cerner by 143.1% in the third quarter. Eagle Asset Management now owns 282,888 shares of the company’s stock valued at $16,960,000 after buying an additional 166,530 shares in the last quarter. Finally, Janus Capital Management increased its position in Cerner by 51.5% in the third quarter. Janus Capital Management now owns 1,830,393 shares of the company’s stock valued at $109,750,000 after buying an additional 622,500 shares in the last quarter.

Cerner Co. (NASDAQ:CERN) traded up 2.78% during midday trading on Friday, hitting $57.38. The stock had a trading volume of 1,527,923 shares. The firm has a market cap of $19.63 billion and a PE ratio of 38.77. Cerner Co. has a one year low of $53.91 and a one year high of $75.72. The stock has a 50-day moving average price of $59.15 and a 200 day moving average price of $62.72.

Cerner (NASDAQ:CERN) last posted its earnings results on Tuesday, November 3rd. The company reported $0.54 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.54. The company earned $1.13 billion during the quarter, compared to analyst estimates of $1.17 billion. Cerner’s quarterly revenue was up 34.1% compared to the same quarter last year. During the same quarter last year, the business posted $0.42 EPS. On average, analysts predict that Cerner Co. will post $2.07 earnings per share for the current year.

CERN has been the subject of a number of analyst reports. Leerink Swann boosted their price objective on Cerner from $70.00 to $80.00 and gave the stock an “outperform” rating in a research report on Monday, November 2nd. KeyBanc boosted their price objective on Cerner from $70.00 to $77.00 and gave the stock a “buy” rating in a research report on Monday, November 2nd. Evercore ISI boosted their price objective on Cerner from $73.50 to $75.50 and gave the stock a “buy” rating in a research report on Monday, November 2nd. RBC Capital boosted their price objective on Cerner from $70.00 to $77.00 and gave the stock an “outperform” rating in a research report on Monday, November 2nd. Finally, Barclays boosted their price objective on Cerner from $71.00 to $75.00 and gave the stock an “outperform” rating in a research report on Monday, November 2nd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. Cerner presently has an average rating of “Buy” and a consensus target price of $73.80.

In other Cerner news, CAO Michael R. Battaglioli sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 10th. The stock was sold at an average price of $60.06, for a total transaction of $120,120.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Julie M. Wilson sold 2,821 shares of the firm’s stock in a transaction that occurred on Monday, December 14th. The shares were sold at an average price of $60.52, for a total value of $170,726.92. Following the sale, the executive vice president now owns 32,895 shares of the company’s stock, valued at approximately $1,990,805.40. The disclosure for this sale can be found here.

Cerner Corporation (NASDAQ:CERN) is a supplier of health care information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations. The Company offers software, hardware, professional services and managed services. The Company operates in two segments: Domestic and Global. The Domestic segment includes the business activity in the United States. The Global segment includes the business activity in Aruba, Australia, Austria, Brazil, Canada, Cayman Islands, Chile, Egypt, England, Finland, France, Germany, Guam, India, Ireland, Israel, Malaysia, Mexico, Netherlands, Qatar, Saudi Arabia, Singapore, Spain, Switzerland and the United Arab Emirates. Cerner solutions are offered on the unified Cerner Millennium architecture and on the HealtheIntent cloud-based platform. Its solutions include HealtheRegistries, Cerner ITWorks, Cerner RevWorks, PowerWorks and CommunityWorks, among others.

12 Month Chart for NASDAQ:CERN

Receive News & Ratings for Cerner Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Co. and related companies with MarketBeat.com's FREE daily email newsletter.